Regulates mood Using peptides therapy, mood is regulated, mental clarity is enhanced, memory and cognition are reinforced, and sleeping patterns are improved
Meanwhile, Nausea is the most common adverse reaction reported with the approved product
Retatrutide Trial Results Retatrutide first turned heads during its phase 2 trials, where participants at the highest doses achieved up to a 24% average weight reduction in just 48 weeks
However, there is much more to losing weight than simply reducing your intake
After about a year, many reach 1522% total weight loss when they stay consistent with the medication and follow nutrition guidance
The Swiss drugmaker plans to leverage its existing production site in Kundl, Austria, to manufacture Zinnat